Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hisao Endo is active.

Publication


Featured researches published by Hisao Endo.


Microbiology and Immunology | 1989

Protection of OK-432, a Streptococcus pyogenes preparation, against lethal infection of mice with herpes simplex virus

Yusuke Harada; Eri Kurokawa; Hisao Endo; Takao Kimura; Motoo Saito; Yutaka Sugawara; Hiroshi Irie; Kyogo Ito; Masahiko Fujii; Yoshinobu Shimizu; Katsuo Kumagai

We have studied the protective effect of OK‐432, a biological response modifier (BRM) of Streptococcus pyogenes origin, on the lethal infection of mice with herpes simplex virus (HSV)‐1. A single intraperitoneal (i.p.) injection of more than 10 μg of OK‐432, when given at least two days before the infection, gave a marked effect yielding nearly 100% protection against ordinarily lethal infection. The protection was independent of the amount of infected virus inoculated. When given after the infection, the agent even at the maximal dose (100 μg), produced only a marginal effect. A single i.p. administration of OK‐432 augmented the natural killer (NK) activity of peritoneal exudate cells and spleen mononuclear cells in mice 2 to 3 days after injection of OK‐432, coinciding with the times when it induced a survival effect on HSV‐infection. Treating OK‐432‐treated mice with a combination of an anti‐macrophage agent, silica, and an anti‐NK cell agent, anti‐asialo GM1 serum, before infection diminished the antiviral effect of OK‐432. The OK‐432 protection against HSV infection was also markedly diminished in athymic nude mice. Thus, the protective effect of OK‐432 on lethal HSV infection seems to be based on the activation of NK cells, macrophages, and T lymphocytes.


The Journal of Antibiotics | 1982

Thiolactomycin, a new antibiotic. III. In vitro antibacterial activity.

Takao Noto; Satohide Miyakawa; Hideo Oishi; Hisao Endo; Hiroshi Okazaki


The Journal of Antibiotics | 1978

Funiculosin, a new antibiotic. II. Structure elucidation and antifungal activity.

Kunio Ando; Ikutoshi Matsuura; Yoshiharu Nawata; Hisao Endo; Hiroshi Sasaki; Tsuneo Okytomi; Tetsuji Saehi; Gakuzo Tamura


The Journal of Antibiotics | 1976

CEFTEZOLE, A NEW CEPHALOSPORIN C DERIVATIVE

Takao Noto; Toshiyuki Nehashi; Hisao Endo; Motoo Saito; Shuzo Matsubara; Yusuke Harada; Seikichi Suzuki; Haruki Ogawa; Kenjiro Koyama; Yasuko Kaneko; Sachiko Goto


Archive | 1979

Penicillanic acid derivatives

Nobuhiro Oi; Bunya Aoki; Teizo Shinozaki; Kanji Moro; Isao Matsunaga; Takao Noto; Toshiyuki Nebashi; Yusuke Harada; Hisao Endo; Takao Kimura; Hiroshi Okazaki; Haruki Ogawa; Minoru Shindo


Archive | 1981

Alpha-substituted ureidobenzylpenicillanic acid

Bunya Aoki; Hisao Endo; Yusuke Harada; Takao Kimura; Kana Kojima; Toshio Kuroki; Masahiko Matsumoto; Isao Matsunaga; Kanji Moro; Toshiyuki Nehashi; Takao Nofuji; Haruki Ogawa; Nobuhiro Oi; Hiroshi Okazaki; Minoru Shindo; Teizo Shinozaki


Archive | 1981

Alpha-substituted ureidobenzylpenicillanic acid derivatives and process for producing the same

Nobuhiro Oi; Bunya Aoki; Teizo Shinozaki; Kanji Moro; Toshio Kuroki; Isao Matsunaga; Takao Noto; Toshiyuki Nebashi; Yusuke Harada; Hisao Endo; Takao Kimura; Kana Kojima; Masahiko Matsumoto; Hiroshi Okazaki; Haruki Ogawa; Minoru Shindo


Japanese Journal of Chemotherapy | 1979

A NEW AND SIMPLE EXPERIMENTAL PYELONEPHRITIS MODEL IN RATS

Shuzo Matsubara; Hisao Endo; Rikio Niki; Haruki Ogawa; Kenjiro Koyama


Archive | 1984

ALPHA-SUBSTITUIERTE UREID OBENZYLPENIZILLANSAEUREDERIVATE UND VERFAHREN ZU IHRER HERSTELLUNG.

Nobuhiro Oi; Bunya Aoki; Teizo Shinozaki; Kanji Moro; Toshio Kuroki; Isao Matsunaga; Takao Noto; Toshiyuki Nebashi; Yusuke Harada; Hisao Endo; Takao Kimura; Kana Kojima; Masahiko Matsumoto; Hiroshi Okazaki; Haruki Ogawa; Minoru Shindo


Archive | 1982

ALPHA-SUBSTITUTED UREIDOBENZYLPENICILLANIC ACID AND PROCESS FOR THE SAME

Nobuhiro Oi; Bunya Acki; Teizo Shinozaki; Kanji Moro; Toshio Kuroki; Isao Matsunaga; Takao Noto; Toshiyuki Nebashi; Yusuke Harada; Hisao Endo; Takao Kimura; Kana Kojima; Masahiko Matsumoto; Hiroshi Okazaki; Haruki Ogawa; Minoru Shindo

Collaboration


Dive into the Hisao Endo's collaboration.

Top Co-Authors

Avatar

Haruki Ogawa

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Yusuke Harada

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Takao Noto

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Takao Kimura

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Hiroshi Okazaki

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Isao Matsunaga

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Minoru Shindo

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Teizo Shinozaki

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Bunya Aoki

Chugai Pharmaceutical Co.

View shared research outputs
Top Co-Authors

Avatar

Kanji Moro

Chugai Pharmaceutical Co.

View shared research outputs
Researchain Logo
Decentralizing Knowledge